Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications

Overview

This protocol describes a non-emulsion-based method for the fabrication of chitosan microgels that are biocompatible and suitable for tissue engineering applications. The microgels can be precisely controlled in size, exhibit pH-dependent swelling, and allow for sustained release of therapeutic molecules.

Key Study Components

Area of Science

• Tissue Engineering
• Biomaterials
• Drug Delivery Systems

Background

• Chitosan is a biodegradable polymer used in various biomedical applications.
• Traditional methods for microgel fabrication often involve toxic solvents.
• There is a need for biocompatible methods that are translatable to clinical settings.
• This protocol aims to address these needs by providing a safer fabrication technique.

Purpose of Study

• To develop a non-toxic method for creating chitosan microgels.
• To enable the use of these microgels in tissue engineering and drug delivery.
• To provide a protocol that is easy to implement without special equipment.

Methods Used

• Preparation of a 6% weight-by-volume chitosan solution using acetic acid.
• Fabrication of microgels without the use of toxic solvents or emulsion techniques.
• Characterization of microgel properties such as size and swelling behavior.
• Evaluation of drug loading and release profiles.

Main Results

• The microgels can be fabricated with precise size control.
• They exhibit pH-dependent swelling behavior.
• Microgels degrade in vivo, making them suitable for biological applications.
• Therapeutic molecules can be loaded and released in a sustained manner.

Conclusions

• This method provides a biocompatible alternative for microgel fabrication.
• Chitosan microgels have potential applications in regenerative medicine.
• The technique can be adapted for various therapeutic uses.

Frequently Asked Questions